How to Buy Kiniksa Pharmaceuticals International Stock

Kiniksa Pharmaceuticals International PLC

Kiniksa Pharmaceuticals, Ltd. , a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide.

Kiniksa Pharmaceuticals International stock last closed at $33.75, up 0.51% from the previous day, and has increased 28.77% in one year. It has overperformed other stocks in the Biotechnology industry by 0.89 percentage points. Kiniksa Pharmaceuticals International stock is currently +89.39% from its 52-week low of $17.82, and -2.3% from its 52-week high of $34.55.

At the moment, there are 74.11M KNSA shares outstanding. The market value of KNSA is $2.50B. In the last 24 hours, 356,000 KNSA shares were traded.

How to Buy Kiniksa Pharmaceuticals International Stock

Not sure how to invest in Kiniksa Pharmaceuticals International stock? Here's how.

  1. Choose where to buy Kiniksa Pharmaceuticals International stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Kiniksa Pharmaceuticals International stock.
  2. Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit money your investment account: Select your payment method and add your details.
  4. Evaluate Kiniksa Pharmaceuticals International stock: The Kiniksa Pharmaceuticals International ticker symbol is KNSA. Is Kiniksa Pharmaceuticals International stock a good investment? Should you buy shares of KNSA? How do KNSA's underlying business fundamentals look? Do top analysts think Kiniksa Pharmaceuticals International is a good buy? Why has KNSA's stock price moved recently? (Hint: Our stock analysis website can help you understand if KNSA is a good stock to buy).
  5. Place your KNSA purchase: Decide if you will purchase KNSA shares at the current market price or use a limit order to buy KNSA shares at a given price.
  6. Keep tabs on your KNSA investment: Create a watchlist to important notifications about your position in Kiniksa Pharmaceuticals International stock.

Step 1: Choose where to buy Kiniksa Pharmaceuticals International stock

You will need a brokerage account in order to access the NASDAQ market and buy KNSA stock.

A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our research, eToro is the best stock brokerage. eToro gives you:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to world markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected the right brokerage, you need to fill out some personal information so you are able to invest in KNSA stock today.

How to Open a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to create your new trading account.
  1. Send your details by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your investment account

Now that you've filled out your info on stock market apps, you can securely and quickly fund your account:

Watch the video below to see the process of depositing money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Kiniksa Pharmaceuticals International stock

After you have chosen the best place to buy Kiniksa Pharmaceuticals International stock, it's critical to analyze their stock prior to buying, so you can understand the risk as well as the opportunity.

Kiniksa Pharmaceuticals International shares quick numbers

KNSA Price
$33.75
1w %
1.11%
1y %
28.77%
5y %
95.2%
P/E
562.5x
P/B
5.05x
P/S
4.68x
PEG
2.46x
Revenue
$529.33M
Earnings
$4.79M
Fore. Rev. Growth
21.07%
Fore. Earn. Growth
229.06%
Market Cap
$2.50B
Next Earnings
N/A
Next Dividend
N/A

Fundamentals of KNSA

WallStreetZen was designed to help part-time investors do better fundamental analysis quickly.

You can see all of the due diligence checks on KNSA's stock page.

Is KNSA stock undervalued?

Analysts use many financial metrics, analyses, models, and charts to gauge KNSA's intrinsic value.

Using relative valuations methods:

  • KNSA could be undervalued based on its P/E ratio of 562.5x, relative to Biotechnology industry P/E ratio of -111.74x
  • KNSA could be overvalued based on its P/B ratio of 5.05x, relative to Biotechnology industry P/B ratio of 4.61x
  • KNSA could be overvalued based on its PEG ratio of 2.46x

You can do additional valuation research on KNSA's stock here.

Is KNSA a healthy company?

Signs that KNSA is financially healthy:

  • KNSA has a low debt to equity ratio of 0.34.
  • There are more short-term assets than short-term liabilities on the KNSA balance sheet.
  • KNSA profit margin has gone up from -3% to 0.9% in the past year.
  • There are more short-term assets than long-term liabilities on the KNSA balance sheet.
  • KNSA's operating cash flow of $66.95M allows it to safely service it's debt of $9.77M.
  • KNSA earnings of $14.26M is not enough to cover its interest payments.

Signs that KNSA is not financially healthy:

  • Total KNSA debt is higher than 5 years ago, relative to shareholder equity.

Is KNSA stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 4 Equities analysts who monitor KNSA, the consensus analyst rating on Kiniksa Pharmaceuticals International is a Strong Buy

It's important to note that analyst ratings are not recommendations, nor are they financial advice.

You can dive deeper into what analysts are forecasting on the Kiniksa Pharmaceuticals International stock forecast page.

KNSA Trading Indicators

SMA10
33.32
SMA20
32.35
SMA50
29.78
SMA100
27.28
SMA200
24.07
MACD
1.22
MACD Signal
1.24
MACD Histogram
-0.02
RSI
65.78
Stochastic %K
68.9
Stochastic %D
70.62
StochRSI %K
21.94
StochRSI %D
21.68

KNSA Growth Numbers

Last year, KNSA earnings were $4.79M. During the last 2 year, KNSA's earnings have grown by -86.56% per year. This was slower than the Biotechnology industry average of 9.05%.

Last year, KNSA revenue was $529.33M. During the last four year, KNSA's revenue has gone up by 187.91% per year. This was faster than the Biotechnology industry average of 65.21%.

You can research KNSA's earnings and revenue performance here.

Are KNSA executives and large shareholders buying or selling the stock?

In the past 12 months, insiders at KNSA have sold more shares than they have bought.

Eben Tessari, CHIEF OPERATING OFFICER of KNSA, was the latest KNSA insider to buy. They bought $57,395.00 worth of KNSA shares on Aug 18, 2025.

Learn more about who owns KNSA shares here.

Does KNSA stock generate passive income?

No, Kiniksa Pharmaceuticals International doesn't provide an income stream by paying out dividends.

KNSA Social Trading Data

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other community members have to say.

Step 5: Place your KNSA purchase

You have two primary order types:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are generally the easiest way to buy.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at an exact price limit, use a limit order.

Click the Open Trade button and your broker will place the order.

If you require additional help buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Keep tabs on your KNSA investment

Now that you own some shares in KNSA, you'll want to keep up with your new investment.

Create a watchlist to get notified of important updates regarding your KNSA stock.

KNSA Feed

How to Buy Stock in Kiniksa Pharmaceuticals International

To reiterate, here are the 6 steps you need to take to buy Kiniksa Pharmaceuticals International stock right now:

  1. Choose where to buy Kiniksa Pharmaceuticals International stock
  2. Open your brokerage account
  3. Deposit money your investment account
  4. Evaluate Kiniksa Pharmaceuticals International stock
  5. Place your KNSA purchase
  6. Keep tabs on your KNSA investment

If you are looking for a place to buy stocks, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get the latest news on your new investment in Kiniksa Pharmaceuticals International, click the button below.

NASDAQ: KNSA
$33.75+0.17 (+0.51%)
Updated Aug 22, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: KNSA
$33.75+0.17 (+0.51%)
Updated Aug 22, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Kiniksa Pharmaceuticals International share?

As of Aug 22, 2025, it costs $33.75 to buy one share of Kiniksa Pharmaceuticals International stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.296 shares of KNSA.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Kiniksa Pharmaceuticals International stock?

According to 4 Wall Street analysts who monitor Kiniksa Pharmaceuticals International, their consensus recommendation is to buy Kiniksa Pharmaceuticals International stock.

What is the best way to buy Kiniksa Pharmaceuticals International stock?

One way to place an order for Kiniksa Pharmaceuticals International stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.